创办百济神州之前，欧雷强先生创立了保诺科技公司（位于北京的综合研究外包研发机构，员工700人），该公司后被 PPD 公司收购并给投资者带来了丰厚的回报。欧雷强先生还曾担任Galenea公司（位于美国波士顿的生物科技公司）首席执行官，Genta公司（公开交易的抗肿瘤药物研发公司）联席首席执行官，Telephia公司（移动通信公司，后被尼尔森公司收购）创始人和总裁。
John Oyler is a native of Pittsburgh, Pennsylvania, a serial entrepreneur and a pioneer in China’s biotechnology industry. He is currently the Founder & CEO of BeiGene, a 150-person, Beijing-based life sciences company focusing on discovering and developing innovative oncology drugs to address unmet medical needs in the China and Asia-Pacific region. In 2011, John was designated by the Chinese Government as a “Zhongguan Cun Leading Talent,” an award that resulted in a 1 Million RMB grant for BeiGene.
Prior to BeiGene, John founded BioDuro, a 700-person integrated research CRO in Beijing later sold to PPD with attractive returns. John has also served as the CEO of Galena, a Boston-based biotech company, the Co-CEO of Genta, a publically-traded oncology company and as the Former Founder and President of Telephia, a mobile company eventually bought by Nielsen.
John spent his early career at McKinsey & Company. He earned his bachelor’s degree at MIT in Biomechanical Engineering and his MBA at Stanford University’s Graduate School of Business.